Astrogen, Inc.
PrivateLast Round
Series C
Jan 31, 2024
Est. Valuation
$52.1M
Total Funding Raised
$35.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Astrogen, Inc. is a biotechnology company that develops small molecule-based therapies for neurological disorders such as Autism Spectrum Disorder (ASD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astrogen, Inc. Comparables
Compare Astrogen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yamo Pharmaceuticals | 83% | |
| STALICLA | 81% | |
| Neurotech International Ltd | 81% | |
Astrogen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 31, 2024 | ||||
| Strategic | Nov 29, 2023 | ||||
| Series B Extension | Jan 21, 2022 | ||||
| Series B | Dec 15, 2020 | ||||
| Series A | Nov 18, 2019 |
Astrogen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Albatross Investment | Series B |
| BSK Investment | Series B |
| Wonik Investment Partners | Series B Extension |
| Daesung Private Equity | Series B |
| IBK Capital | Series B |
| ROI Investment Partners | Series B, Series A |
| KB Securities | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 47% MoM.
- Jan 31, 2024
Raised $9.4M from JCH-Kangwon National University Technology Holdings and KOREA PHARMA.
Astrogen, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Astrogen, Inc.'s valuation, stock price, and market status.